Li-Fraumeni Syndrome clinical trials
The registry lists 25 studies for Li-Fraumeni Syndrome across more than 10 countries. 16 are recruiting or about to start. 17 of them are mainly about Li-Fraumeni Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.
Get an email when these change. Save the Li-Fraumeni Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
National Cancer Institute (NCI) (5) · Royal Marsden NHS Foundation Trust (2) · Gustave Roussy, Cancer Campus, Grand Paris (2) · Dana-Farber Cancer Institute (2) · National Heart, Lung, and Blood Institute (NHLBI) (2) · M.D. Anderson Cancer Center (1) · Yang Li (1) · The Hospital for Sick Children (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 4
- Dec 2026Li-Fraumeni Syndrome Imaging Study · The Hospital for Sick Children
- Feb 2027Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer · Sir Mortimer B. Davis - Jewish General Hospital
- Feb 2027Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling · M.D. Anderson Cancer Center
- Mar 2027Reduce All Avoidable Cancer-promoting Exposures in Individuals at High Genetic Risk of Cancer Carrying a Constitutional Variant of the TP53 Gene · Gustave Roussy, Cancer Campus, Grand Paris
Who these studies take
Of the 13 Li-Fraumeni Syndrome studies recruiting now, 9 (69%) set no upper age limit and 1 (8%) stop at 75 or younger. 9 (69%) take children under 18. 1 (8%) are for women only and 0 (0%) for men only; 5 (38%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 9 (69%) | 9 (69%) |
| 18 | 13 (100%) | 12 (92%) |
| 30 | 12 (92%) | 11 (85%) |
| 40 | 12 (92%) | 11 (85%) |
| 50 | 12 (92%) | 11 (85%) |
| 65 | 12 (92%) | 11 (85%) |
| 75 | 12 (92%) | 11 (85%) |
| 85 | 12 (92%) | 11 (85%) |
Across all 25 studies, recruiting or not: 20% stop at 75 or younger and 16% at 65; 56% take children; 4% are for women only and 0% for men only; 32% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 15, 2026.
Newly registered1
Studies
Recruiting first, then most recently updated. Showing 25 of 25. search them.
- Clinical Genetics Branch Eligibility Screening SurveyNot yet recruitingNCT070052971 country
- Clinical and Genetic Studies of Li-Fraumeni SyndromeRecruitingNCT014434681 country
- Reduce All Avoidable Cancer-promoting Exposures in Individuals at High Genetic Risk of Cancer Carrying a Constitutional Variant of the TP53 GeneNot yet recruitingNCT07921537Not applicable1 country
- Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular SystemRecruitingNCT011434541 country
- CfDNA in Hereditary And High-risk Malignancies 2RecruitingNCT067266421 country
- Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic CounselingRecruitingNCT051268101 country
- Li-Fraumeni Syndrome/TP53 BiobankRecruitingNCT043672461 country
- Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast CancerRecruitingNCT068883888 countries
- Familial Investigations of Childhood Cancer PredispositionRecruitingNCT030502681 country
- Li-Fraumeni Syndrome Imaging StudyEnrolling by invitationNCT03176836Not applicable1 country
- Li-Fraumeni & TP53 (LiFT UP): Understanding and ProgressRecruitingNCT045416541 country
- Registry of Li Fraumeni and Li Fraumeni Like SyndromesRecruitingNCT049827441 country
- Video Capsule Examination in Patients With Lynch SyndromeRecruitingNCT06712095Not applicable1 country
- Genetic Bases of Neuroendocrine Neoplasms in Mexican PatientsRecruitingNCT065235821 country
- Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric CancerRecruitingNCT06088030Phase 21 country
- Inherited Cancer Early Diagnosis (ICED) StudyRecruitingNCT061633651 country
- Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian CancerCompletedNCT000402221 country
- Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition SyndromesActive, not recruitingNCT02950987Not applicable1 country
- Exploring How to Adapt an Evidence-Based Mindful Self-Compassion Program for Young Adults With Li-Fraumeni SyndromeCompletedNCT070329221 country
- Phenotype and Prognosis of Patients With Breast Cancer and Pathogenic Variants of TP53CompletedNCT049669231 country
- Magnetic Resonance Imaging Screening in Li Fraumeni SyndromeCompletedNCT017372551 country
- Role of p53 Gene in Metabolism Regulation in Patients With Li-Fraumeni SyndromeCompletedNCT004064451 country
- LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome)CompletedNCT01464086Phase 31 country
- A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni SyndromeCompletedNCT01981525Phase 11 country
- Biomarker Monitoring in TP53 Mutation CarriersCompletedNCT022893261 country